MXL - MaxLinear, Inc.
NYSE
->
Technology
->
Semiconductors
Carlsbad,
United States
Type: Equity
MXL price evolution
MXL
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $186.11 | $192.91 | $188.34 | |
| Short term investments | ||||
| Net receivables | $47.93 | $84.94 | $126.23 | $170.62 |
| Inventory | $96.06 | $94.74 | $96.13 | $99.91 |
| Total current assets | $328.26 | $397.58 | $444.68 | $488.02 |
| Long term investments | $0.02 | $0.02 | $0.02 | |
| Property, plant & equipment | $86.04 | $90.31 | $95.81 | $97.69 |
| Goodwill & intangible assets | $380.37 | $383.53 | $392.22 | |
| Total noncurrent assets | $575.62 | $585.95 | $592.23 | |
| Total investments | $0.02 | $0.02 | $0.02 | |
| Total assets | $895.3 | $973.2 | $1030.63 | $1080.26 |
| Current liabilities | ||||
| Accounts payable | $30.63 | $35.63 | $32.39 | $21.55 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $168.6 | $190.28 | $223.85 | $222.13 |
| Long term debt | $122.84 | $144.21 | $146.43 | $148.62 |
| Total noncurrent liabilities | $165.66 | $168.79 | $171.86 | |
| Total debt | $144.21 | $146.43 | $148.62 | |
| Total liabilities | $338.43 | $355.94 | $392.64 | $393.99 |
| Shareholders' equity | ||||
| Retained earnings | -$305.89 | -$230.1 | -$190.84 | -$118.53 |
| Other shareholder equity | -$3.85 | -$6.52 | -$5.57 | -$3.79 |
| Total shareholder equity | $617.25 | $637.98 | $686.26 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $188.34 | $188.34 | $130.68 | $149.02 |
| Short term investments | $18.53 | |||
| Net receivables | $170.62 | $170.97 | $119.72 | $67.44 |
| Inventory | $99.91 | $160.54 | $131.7 | $97.84 |
| Total current assets | $488.02 | $563.12 | $404.1 | $361.72 |
| Long term investments | $0.02 | $0.02 | $1.06 | $1.02 |
| Property, plant & equipment | $97.69 | $107.53 | $88.19 | $61.36 |
| Goodwill & intangible assets | $392.22 | $416.06 | $459.21 | $510.09 |
| Total noncurrent assets | $592.23 | $616.9 | $646.28 | $660.72 |
| Total investments | $0.02 | $18.55 | $1.06 | $1.02 |
| Total assets | $1080.26 | $1180.03 | $1050.38 | $1022.44 |
| Current liabilities | ||||
| Accounts payable | $21.55 | $68.58 | $52.98 | $32.75 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $222.13 | $341.09 | $207.4 | $233.66 |
| Long term debt | $148.62 | $121.76 | $330.79 | $384.45 |
| Total noncurrent liabilities | $171.86 | $162.55 | $353.79 | $397.66 |
| Total debt | $148.62 | $145.11 | $330.79 | $384.45 |
| Total liabilities | $393.99 | $503.64 | $561.19 | $631.33 |
| Shareholders' equity | ||||
| Retained earnings | -$118.53 | -$45.38 | -$170.42 | -$212.39 |
| Other shareholder equity | -$3.79 | -$1.02 | $2.13 | $1.44 |
| Total shareholder equity | $686.26 | $676.38 | $489.2 | $391.12 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $81.1 | $91.99 | $95.27 | $125.35 |
| Cost of revenue | $41.8 | $46 | $56.81 | |
| Gross Profit | $44.08 | $50.19 | $49.27 | $68.54 |
| Operating activities | ||||
| Research & development | $56.54 | $64.77 | $65.25 | |
| Selling, general & administrative | $33.6 | $36.49 | $34.38 | |
| Total operating expenses | $82.76 | $91.01 | $123.88 | $110.28 |
| Operating income | -$40.82 | -$74.62 | -$41.74 | |
| Income from continuing operations | ||||
| EBIT | -$38.62 | -$71.36 | -$39.72 | |
| Income tax expense | -$6.71 | -$2.06 | -$1.76 | -$4.13 |
| Interest expense | -$1 | $2.71 | $2.71 | $2.91 |
| Net income | ||||
| Net income | -$75.78 | -$39.27 | -$72.31 | -$38.5 |
| Income (for common shares) | -$39.27 | -$72.31 | -$38.5 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $693.26 | $1120.25 | $892.4 | $478.6 |
| Cost of revenue | $307.6 | $470.48 | $396.57 | $265.8 |
| Gross Profit | $385.66 | $649.77 | $495.83 | $212.8 |
| Operating activities | ||||
| Research & development | $269.5 | $296.44 | $278.44 | $179.99 |
| Selling, general & administrative | $132.16 | $168.01 | $149.94 | $130.03 |
| Total operating expenses | $423.88 | $469.53 | $430.59 | $313.94 |
| Operating income | -$38.22 | $180.24 | $65.25 | -$101.14 |
| Income from continuing operations | ||||
| EBIT | -$53.11 | $183.97 | $60.87 | -$101.9 |
| Income tax expense | $9.34 | $49.16 | $5.9 | -$16.26 |
| Interest expense | $10.7 | $9.77 | $13 | $12.95 |
| Net income | ||||
| Net income | -$73.15 | $125.04 | $41.97 | -$98.59 |
| Income (for common shares) | -$73.15 | $125.04 | $41.97 | -$98.59 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$39.27 | -$72.31 | -$38.5 | |
| Operating activities | ||||
| Depreciation | $13.6 | $16.68 | $16.59 | |
| Business acquisitions & disposals | -$0.94 | |||
| Stock-based compensation | $14.47 | $18.43 | $16.69 | |
| Total cash flows from operations | -$2.7 | $15.97 | -$16.57 | |
| Investing activities | ||||
| Capital expenditures | -$3.01 | -$8.34 | -$1.27 | |
| Investments | $17.2 | |||
| Total cash flows from investing | -$20.45 | -$5.79 | -$8.71 | $14.83 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.58 | $1.39 | ||
| Net borrowings | -$18.32 | |||
| Total cash flows from financing | -$0.14 | $2.03 | -$2.1 | $1.17 |
| Effect of exchange rate | -$0.82 | -$0.34 | -$0.58 | $0.78 |
| Change in cash and equivalents | -$38.86 | -$6.79 | $4.57 | $0.2 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$73.15 | $125.04 | $41.97 | -$98.59 |
| Operating activities | ||||
| Depreciation | $71.52 | $80.73 | $91.79 | $76.51 |
| Business acquisitions & disposals | -$13.32 | -$40 | -$160 | |
| Stock-based compensation | $54.92 | $71.78 | $51.94 | $46.92 |
| Total cash flows from operations | $43.37 | $388.73 | $168.23 | $73.59 |
| Investing activities | ||||
| Capital expenditures | -$13.45 | -$41.25 | -$39.18 | -$12.49 |
| Investments | $17.2 | -$39.33 | -$5 | |
| Total cash flows from investing | -$15.94 | -$91.76 | -$91.76 | -$175.29 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.56 | -$26.5 | -$14.77 | $8.07 |
| Net borrowings | -$18.32 | -$185 | -$63.99 | $155.12 |
| Total cash flows from financing | -$26.36 | -$240.4 | -$91.9 | $159.65 |
| Effect of exchange rate | -$1.08 | $0.06 | -$2.87 | -$1.04 |
| Change in cash and equivalents | -$0 | $56.62 | -$18.3 | $56.92 |
News
Fundamentals
| Market cap | $1.33B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 84.36M |
| Revenue | $393.71M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$225.86M |
| Revenue Q/Q | -40.16% |
| Revenue Y/Y | -54.14% |
| P/E ratio | -5.88 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 3.37 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$2.68 |
|---|---|
| ROA | -22.70% |
| ROE | N/A |
| Debt/Equity | 0.57 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.95 |
| Quick ratio | 1.38 |